BioHarvest Sciences Inc (BHST) (Q3 2026) Earnings Call Highlights: Revenue Decline, Revised ...
BioHarvest Sciences Inc (BHST) posted Q3 2026 revenue of $7.9 million and widened its net loss to $3.3 million, while landing a rare fragrance CDMO deal worth an estimated $20 million to $30 million Related Stocks: BHST ,